Hutchmed (China) Limited

Declaration of Voting Results & Voting Rights Announcements • Feb 28, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8085Y

Hutchison China Meditech Limited

28 February 2013

Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Total Voting Rights

London: Thursday, 28 February 2013: For information purposes, Chi-Med hereby notifies the market that as at 28 February 2013, the issued share capital of the Company consisted of 52,051,448 ordinary shares of US$1.00 each, with each share carrying one right to vote and with no shares held in treasury.

The above figure of 52,051,448 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Chi-Med under the FSA's Disclosure Rules and Transparency Rules.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      +852 2121 8200
Panmure Gordon (UK) Limited	Telephone:      +44 20 7886 2500
Richard Gray Andrew Potts Grishma Patel
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      +44 20 7638 9571 Mobile:             +44 7973 611 888 Mobile:             +44 7967 566 919

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVREALAXAEADEFF